Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20150206020981N3
IRCT20150206020981N3
Recruiting
未知

Evaluation of safety and efficacy of autologous adipose-derived mesenchymal cells therapy in Duchenne muscular dystrophy patients

Research Deputy of Islamic Azad University, Tehran Medical Branch0 sites10 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Research Deputy of Islamic Azad University, Tehran Medical Branch
Enrollment
10
Status
Recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Research Deputy of Islamic Azad University, Tehran Medical Branch

Eligibility Criteria

Inclusion Criteria

  • •Genetic evidence of Duchenne disease as a cause of myopathy
  • •The patient's ability to walk is not completely lost and the use of assistive devices such as canes and walkers is not permanent.
  • •The patient's muscle strength is decreasing
  • •Willingness and satisfaction to participate in the study by the patient's legal guardian in decision making and willingness to participate regularly in follow\-up courses

Exclusion Criteria

  • •Advanced motor impairment leading to permanent use of crutches, walkers and wheelchairs
  • •A history of known malignancy
  • •History of associated genetic and non\-genetic degenerative diseases
  • •Having blood and internal diseases that increase the risk of liposuction and anesthesia required
  • •A history of any other acute or chronic illness that, at the discretion of the clinician responsible for implementing the plan, prevents the patient from entering the study.
  • •Insufficient volume of subcutaneous fat or the presence of concomitant injuries in the abdomen in the initial examination that make it difficult to obtain adipose tissue to prepare SVF.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Clinical Study of Safety and Efficacy of Autologous Mesenchymal Stem Cells for Periodontal Tissue Regeneration TherapyPeriodontal Disease
JPRN-jRCTb070230008Cho Yasushi22
Recruiting
Phase 1
Fibroblast in Cutaneous Leishmaniasis
IRCT20150715023218N1Iran University of Medical Sciences5
Completed
Not Applicable
Evaluation of safety and efficacy of autologous stentless mitral valve replacement: pilot studymitral valve stenosis, mitral valve stenosis and regurgitation
JPRN-UMIN000026020Kyoto Prefectural University of Medicine
Not yet recruiting
Phase 1
Evaluation of autologous cell transplantation without melanocyte-keratinocyte culture in suspension and gel form in the treatment of patients with persistent vitiligoVitiligo.disorders of pigmentation
IRCT20200127046282N22Tehran University of Medical Sciences10
Completed
Not Applicable
Tissue engineered autologous grafting versus standard care in the treatment of diabetic foot ulcersDiabetic foot ulcerNutritional, Metabolic, EndocrineNon-insulin-dependent diabetes mellitus
ISRCTN66756247Fidia Advanced Biopolymers Srl (Italy)200